CGP + MRD testing
The power of pairing
Get a more complete picture of your patient’s advanced solid tumor by pairing the OncoExTra® comprehensive genomic profiling test with the Oncodetect® molecular residual disease test.
A healthcare provider going over test results with a patient.
Combine CGP and MRD testing for more confident advanced cancer care planning
Comprehensive genomic profiling (CGP) helps guide therapy selection in late-stage cancers. Molecular residual disease (MRD) testing can monitor therapy response and reveal evidence of cancer recurring, progressing or regressing. Together, they provide actionable insights that enable proactive, personalized advanced cancer care.
Comprehensive genomic profiling (CGP)
  • Identifies genomic alterations for personalized therapy selection in patients with advanced, metastatic, refractory, relapsed, or recurrent solid tumors
  • Identifies potential targeted therapies, immunotherapies, and clinical trials
Molecular residual disease (MRD) testing
  • Detects minuscule amounts of ctDNA during or after treatment
  • Helps guide personalized follow-up care throughout the care continuum

Two tests, one clearer path forward
The OncoExTra test can help guide therapy selection, while the Oncodetect test assesses patient response to the treatment selected. Ordering both tests can help you form a more complete strategy for late-stage cancer management. The dual-ordering process on the Exact Sciences Provider Hub is simple, and both tests can leverage the same tissue and blood samples if ordered at the same time.
A man in a t-shirt looking off to the right.
OncoExTra is a CGP test that helps guide therapy selection
Interrogates both DNA and RNA for ultra-comprehensive genomic profiling across nearly 20k genes, to thoroughly detect clinically actionable mutations and fusions1
Identifies potential targeted therapies, immunotherapies and clinical trials
Uses patient-matched tumor-normal sequencing to distinguish actionable somatic variants specific to cancer from likely benign germline variants, refining therapy selection
Oncodetect is an MRD test that monitors for cancer recurrence
Tracks up to 200 variants specific to your patient’s cancer to detect even a slight amount of ctDNA2
Able to detect cancer recurrence more than 2 years earlier than imaging2
Helps guide decisions regarding adjuvant therapy, cancer recurrence, and response to treatment
A woman in a headwrap looking off into the distance.
Laptop showing the Exact Sciences Provider Hub test order screen, with the Oncodetect™ and OncoExTra® tests selected.
Exact Sciences Provider Hub
Order both tests simply and easily
  • To order the OncoExTra and Oncodetect tests together, just select each test with a click
  • Follow our simplified order process to reduce duplicate data entry
  • Easily set up recurring orders for Oncodetect monitoring tests to see your patient’s ctDNA levels over time
  • Quickly view, track, and sort patient orders and results
Other ways to get started
The Exact Sciences Provider Hub is the quickest and easiest way to place test orders, but here are some other resources you may need.
Specimen kits
Give us a call to get blood and tissue sample test kits sent to your office. Or you can contact your local Exact Sciences sales representative.

Call +1 866-662-6897

Test requisition form
PDF
While it's most efficient to complete your requisition form online, you can also download a copy, complete it, and fax it to +1 608-709-0769.